JAMA Internal Medicine
DECEMBER 8, 2024
This randomized clinical trial compares the effectiveness of an integrated pain team vs pharmacist collaborative management on pain and opioid dosage.
Drug Patent Watch
DECEMBER 8, 2024
The pharmaceutical industry is heavily reliant on patents to protect intellectual property and maintain market exclusivity. However, with the increasing competition from generic and biosimilar manufacturers, patent invalidity claims have become a significant challenge for pharmaceutical companies.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
JAMA Internal Medicine
DECEMBER 8, 2024
This Clinical Insights discusses how the methicillin-resistant Staphylococcus aureus (MRSA) nares swab may be used alongside disease prevalence and clinical factors to determine when MRSA coverage is needed for common inpatient infections.
JAMA Internal Medicine
DECEMBER 8, 2024
This cohort study compares the rates of medical assistance in dying across diseases to understand the relative effects of disease and jurisdiction.
Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
JAMA Internal Medicine
DECEMBER 8, 2024
This cohort study assesses systematic depression screening and recommended initial treatment among those with elevated depressive symptoms and/or suicidal ideation and whether individuals historically at risk for undertreatment received equitable initial care.
Expert insights. Personalized for you.
76 
Let's personalize your content